邁向狙擊之路的个人主页 - 老虎社区

邁向狙擊之路

邁向狙擊之路

暂无个人介绍

IP属地：未知

50关注

40粉丝

0主题

0勋章

邁向狙擊之路

2021-11-18

FDA批准了还跌[惊讶] [惊讶]

抱歉，原内容已删除

邁向狙擊之路

2021-11-17

是今晚9:00開始嗎？[惊讶]

Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.

邁向狙擊之路

2021-11-05

$Alzamend Neuro, Inc(ALZN)$错过了沒话讲[捂脸] [捂脸]

邁向狙擊之路

2021-11-05

$Exela Technologies, Inc.(XELA)$什么事[惊讶] 突然跌这么多

邁向狙擊之路

2021-11-04

$Concord Acquisition Corp III(CNDB.U)$@炮王吴亦凡這妖股還能上天嗎[捂脸] [捂脸] [笑哭]

邁向狙擊之路

2021-11-04

$Cadre Holdings Inc(CDRE)$这是什麼妖股[捂脸] [捂脸]

邁向狙擊之路

2021-11-04

终于都批准了[财迷] [财迷] [看涨] [看涨] 希望一年后能站上$300[捂脸] [捂脸]

默沙东口服新冠药物molnupiravir在英国获得批准

邁向狙擊之路

2021-11-04

$Better Therapeutics(BTTX)$$30冲啊[财迷] [财迷]

邁向狙擊之路

2021-11-01

$Better Therapeutics(BTTX)$去吧[财迷] [财迷] [看涨] [看涨] [看涨]

邁向狙擊之路

2021-11-01

[惊讶]

Golden Star Agrees to $470 Million Takeover by Chifeng Jilong

邁向狙擊之路

2021-10-31

$老虎证券(TIGR)$不懂下星期🈶️沒有机會$5接盘一下下[捂脸]

邁向狙擊之路

2021-10-31

$Innerscope Hearing Technologies, Inc.(INND)$你星期一开始还会涨吗[财迷]

邁向狙擊之路

2021-10-31

[财迷]

邁向狙擊之路

2021-10-29

$Avadel Pharmaceuticals plc(AVDL)$快乐[开心]

邁向狙擊之路

2021-10-27

$Kaival Brands Innovations Group, Inc.(KAVL)$今晚就看你了[开心] [开心]

邁向狙擊之路

2021-10-27

难怪飞漲的这样快[财迷] FDA过了[财迷] [财迷]

FDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends

邁向狙擊之路

2021-10-27

🈶️机会吗[财迷]

腾讯阅文洽谈收购米读业务趣头条“潜力股”存变数？

邁向狙擊之路

2021-10-27

$Exela Technologies, Inc.(XELA)$不知道又🈶️多少人被套了[捂脸]

邁向狙擊之路

2021-10-25

$Benessere Capital Acquisition Corp(BENE)$感觉这个今晚会涨一波[捂脸]

邁向狙擊之路

2021-10-25

$Digital World Acquisition Corp(DWAC)$8点一到就飞漲[捂脸]

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3562033051306615,"uuid":"3562033051306615","gmtCreate":1598944648669,"gmtModify":1612318091975,"name":"邁向狙擊之路","pinyin":"邁xj擊zl邁xiangju擊zhilu","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":40,"headSize":50,"tweetSize":343,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.39%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":876023319,"gmtCreate":1637245988115,"gmtModify":1637245988357,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"FDA批准了还跌[惊讶]&nbsp;[惊讶]&nbsp;","listText":"FDA批准了还跌[惊讶]&nbsp;[惊讶]&nbsp;","text":"FDA批准了还跌[惊讶] [惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876023319","repostId":"2184867063","repostType":2,"isVote":1,"tweetType":1,"viewCount":576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878104086,"gmtCreate":1637156841992,"gmtModify":1637156842191,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"是今晚9:00開始嗎？[惊讶]&nbsp;","listText":"是今晚9:00開始嗎？[惊讶]&nbsp;","text":"是今晚9:00開始嗎？[惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878104086","repostId":"2184832662","repostType":2,"repost":{"id":"2184832662","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637147100,"share":"https://www.laohu8.com/m/news/2184832662?lang=&edition=full","pubTime":"2021-11-17 19:05","market":"hk","language":"en","title":"Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.","url":"https://stock-news.laohu8.com/highlight/detail?id=2184832662","media":"Dow Jones","summary":"MW Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  November 17, 2021 06:05 ET (11:05 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-17 19:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  November 17, 2021 06:05 ET (11:05 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4516":"特朗普概念","BK4007":"制药","MRK":"默沙东","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184832662","content_text":"MW Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antirival at ASTMH meeting at 9. a.m.\n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  November 17, 2021 06:05 ET (11:05 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":847,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842039007,"gmtCreate":1636119750425,"gmtModify":1636119751182,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Alzamend Neuro, Inc(ALZN)$错过了沒话讲[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":13,"repostSize":0,"link":"https://laohu8.com/post/842039007","isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846773919,"gmtCreate":1636118153675,"gmtModify":1636118478404,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>什么事[惊讶]&nbsp;突然跌这么多","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>什么事[惊讶]&nbsp;突然跌这么多","text":"$Exela Technologies, Inc.(XELA)$什么事[惊讶] 突然跌这么多","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846773919","isVote":1,"tweetType":1,"viewCount":3137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846994941,"gmtCreate":1636038439094,"gmtModify":1636038439865,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CNDB.U\">$Concord Acquisition Corp III(CNDB.U)$</a><a href=\"https://laohu8.com/U/3581686650032769\">@炮王吴亦凡</a>這妖股還能上天嗎[捂脸]&nbsp;[捂脸]&nbsp;[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/CNDB.U\">$Concord Acquisition Corp III(CNDB.U)$</a><a href=\"https://laohu8.com/U/3581686650032769\">@炮王吴亦凡</a>這妖股還能上天嗎[捂脸]&nbsp;[捂脸]&nbsp;[笑哭]&nbsp;","text":"$Concord Acquisition Corp III(CNDB.U)$@炮王吴亦凡這妖股還能上天嗎[捂脸] [捂脸] [笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846994941","isVote":1,"tweetType":1,"viewCount":437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846998445,"gmtCreate":1636038335285,"gmtModify":1636038335971,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CDRE\">$Cadre Holdings Inc(CDRE)$</a>这是什麼妖股[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/CDRE\">$Cadre Holdings Inc(CDRE)$</a>这是什麼妖股[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Cadre Holdings Inc(CDRE)$这是什麼妖股[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846998445","isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848783565,"gmtCreate":1636029537761,"gmtModify":1636029554411,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"终于都批准了[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;希望一年后能站上$300[捂脸]&nbsp;[捂脸]&nbsp;","listText":"终于都批准了[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;希望一年后能站上$300[捂脸]&nbsp;[捂脸]&nbsp;","text":"终于都批准了[财迷] [财迷] [看涨] [看涨] 希望一年后能站上$300[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848783565","repostId":"2180952107","repostType":2,"repost":{"id":"2180952107","pubTimestamp":1636026601,"share":"https://www.laohu8.com/m/news/2180952107?lang=&edition=full","pubTime":"2021-11-04 19:50","market":"us","language":"zh","title":"默沙东口服新冠药物molnupiravir在英国获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2180952107","media":"界面新闻","summary":"默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。","content":"<div>\n<p>默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b\">Web Link</a>\n\n</div>\n","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>默沙东口服新冠药物molnupiravir在英国获得批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n默沙东口服新冠药物molnupiravir在英国获得批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 19:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b><strong>界面新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3","relate_stocks":{},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111041951007a06278b&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2180952107","content_text":"默沙东/Ridgeback宣布英国药品和保健产品监管局(MHRA)已在英国批准molnupiravir (MK-4482, EIDD-2801)上市，用于治疗重症和住院风险较高的轻至中度COVID-19成人患者。Molnupiravir是全球首个获批用于治疗成人轻度至中度COVID-19的口服抗病毒药物，这些患者经SARS-CoV-2诊断测试呈阳性且至少存在一个发展为严重疾病的风险因素。","news_type":1},"isVote":1,"tweetType":1,"viewCount":628,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848547318,"gmtCreate":1636015370264,"gmtModify":1636015370521,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>$30冲啊[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>$30冲啊[财迷]&nbsp;[财迷]&nbsp;","text":"$Better Therapeutics(BTTX)$$30冲啊[财迷] [财迷]","images":[{"img":"https://static.tigerbbs.com/d3e492b473cbc91662d8380fac0d9c54","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848547318","isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843030540,"gmtCreate":1635781167609,"gmtModify":1635781167807,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>去吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BTTX\">$Better Therapeutics(BTTX)$</a>去吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Better Therapeutics(BTTX)$去吧[财迷] [财迷] [看涨] [看涨] [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843030540","isVote":1,"tweetType":1,"viewCount":854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849713127,"gmtCreate":1635777077882,"gmtModify":1635777078086,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[惊讶]&nbsp;","listText":"[惊讶]&nbsp;","text":"[惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849713127","repostId":"1184353503","repostType":2,"repost":{"id":"1184353503","pubTimestamp":1635773061,"share":"https://www.laohu8.com/m/news/1184353503?lang=&edition=full","pubTime":"2021-11-01 21:24","market":"us","language":"en","title":"Golden Star Agrees to $470 Million Takeover by Chifeng Jilong","url":"https://stock-news.laohu8.com/highlight/detail?id=1184353503","media":"Bloomberg","summary":"Offer is a 25% premium to Golden Star’s Friday stock price\nDeal gives Shanghai-listed firm access to","content":"<ul>\n <li>Offer is a 25% premium to Golden Star’s Friday stock price</li>\n <li>Deal gives Shanghai-listed firm access to Ghana gold mine</li>\n</ul>\n<p>Canadian miner&nbsp;Golden Star Resources Ltd.&nbsp;agreed to be acquired by&nbsp;Chifeng Jilong Gold Mining Co.&nbsp;in a $470 million deal that gives the Shanghai-listed company access to a gold mine in Ghana.</p>\n<p>Chifeng agreed to pay $3.91 cash for each share of Golden Star in the deal, a 24% premium to Friday’s closing price in New York. Golden Star’s board unanimously approved the transaction and recommends shareholders support the deal, the Toronto-based company said Monday in a&nbsp;statement.</p>\n<p>Golden Star owns and operates the Wassa underground mine in the western region of Ghana in West Africa.</p>\n<p>“We believe that the transaction will benefit all of our stakeholders, with shareholders receiving an attractive premium in return for the future growth potential, and with Wassa forming part of Chifeng’s larger portfolio of gold mines there will be a larger capital base to help deliver that growth,” Golden Star Chief Executive Officer Andrew Wray said Monday in a statement.</p>\n<p>The transaction requires two-third approval from Golden Star investors at a shareholder meeting expected to be held before the end of the year. Golden Star hired&nbsp;Canaccord Genuity Corp.&nbsp;as its financial adviser, while Chifeng hired&nbsp;Stifel Nicolaus Canada&nbsp;and First Asia Group Ltd. as its advisers on the deal.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Golden Star Agrees to $470 Million Takeover by Chifeng Jilong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGolden Star Agrees to $470 Million Takeover by Chifeng Jilong\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 21:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-01/golden-star-agrees-to-470-million-takeover-by-chifeng-jilong?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Offer is a 25% premium to Golden Star’s Friday stock price\nDeal gives Shanghai-listed firm access to Ghana gold mine\n\nCanadian miner Golden Star Resources Ltd. agreed to be acquired by Chifeng Jilong ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-01/golden-star-agrees-to-470-million-takeover-by-chifeng-jilong?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"600988":"赤峰黄金"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-01/golden-star-agrees-to-470-million-takeover-by-chifeng-jilong?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184353503","content_text":"Offer is a 25% premium to Golden Star’s Friday stock price\nDeal gives Shanghai-listed firm access to Ghana gold mine\n\nCanadian miner Golden Star Resources Ltd. agreed to be acquired by Chifeng Jilong Gold Mining Co. in a $470 million deal that gives the Shanghai-listed company access to a gold mine in Ghana.\nChifeng agreed to pay $3.91 cash for each share of Golden Star in the deal, a 24% premium to Friday’s closing price in New York. Golden Star’s board unanimously approved the transaction and recommends shareholders support the deal, the Toronto-based company said Monday in a statement.\nGolden Star owns and operates the Wassa underground mine in the western region of Ghana in West Africa.\n“We believe that the transaction will benefit all of our stakeholders, with shareholders receiving an attractive premium in return for the future growth potential, and with Wassa forming part of Chifeng’s larger portfolio of gold mines there will be a larger capital base to help deliver that growth,” Golden Star Chief Executive Officer Andrew Wray said Monday in a statement.\nThe transaction requires two-third approval from Golden Star investors at a shareholder meeting expected to be held before the end of the year. Golden Star hired Canaccord Genuity Corp. as its financial adviser, while Chifeng hired Stifel Nicolaus Canada and First Asia Group Ltd. as its advisers on the deal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840447524,"gmtCreate":1635680488195,"gmtModify":1635680488475,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>不懂下星期🈶️沒有机會$5接盘一下下[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>不懂下星期🈶️沒有机會$5接盘一下下[捂脸]&nbsp;","text":"$老虎证券(TIGR)$不懂下星期🈶️沒有机會$5接盘一下下[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/840447524","isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840503679,"gmtCreate":1635654673709,"gmtModify":1635654673911,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INND\">$Innerscope Hearing Technologies, Inc.(INND)$</a>你星期一开始还会涨吗[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/INND\">$Innerscope Hearing Technologies, Inc.(INND)$</a>你星期一开始还会涨吗[财迷]&nbsp;","text":"$Innerscope Hearing Technologies, Inc.(INND)$你星期一开始还会涨吗[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840503679","isVote":1,"tweetType":1,"viewCount":517,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840276599,"gmtCreate":1635654061881,"gmtModify":1635654062072,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[{"img":"https://static.tigerbbs.com/682350ef899b5446132a20f339fc703b","width":"550","height":"866"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840276599","isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":857650222,"gmtCreate":1635523078940,"gmtModify":1635523079294,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AVDL\">$Avadel Pharmaceuticals plc(AVDL)$</a>快乐[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AVDL\">$Avadel Pharmaceuticals plc(AVDL)$</a>快乐[开心]&nbsp;","text":"$Avadel Pharmaceuticals plc(AVDL)$快乐[开心]","images":[{"img":"https://static.tigerbbs.com/dad90f9240447facd8619e644abf6cca","width":"750","height":"1464"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857650222","isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855364626,"gmtCreate":1635338048829,"gmtModify":1635338049017,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/KAVL\">$Kaival Brands Innovations Group, Inc.(KAVL)$</a>今晚就看你了[开心]&nbsp;[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/KAVL\">$Kaival Brands Innovations Group, Inc.(KAVL)$</a>今晚就看你了[开心]&nbsp;[开心]&nbsp;","text":"$Kaival Brands Innovations Group, Inc.(KAVL)$今晚就看你了[开心] [开心]","images":[{"img":"https://static.tigerbbs.com/bf4393ddf27c1a2efff4aea99f96e1a5","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855364626","isVote":1,"tweetType":1,"viewCount":721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":855365167,"gmtCreate":1635337992611,"gmtModify":1635337992791,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"难怪飞漲的这样快[财迷]&nbsp;FDA过了[财迷]&nbsp;[财迷]&nbsp;","listText":"难怪飞漲的这样快[财迷]&nbsp;FDA过了[财迷]&nbsp;[财迷]&nbsp;","text":"难怪飞漲的这样快[财迷] FDA过了[财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855365167","repostId":"2178426233","repostType":2,"repost":{"id":"2178426233","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1635336916,"share":"https://www.laohu8.com/m/news/2178426233?lang=&edition=full","pubTime":"2021-10-27 20:15","market":"us","language":"en","title":"FDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends","url":"https://stock-news.laohu8.com/highlight/detail?id=2178426233","media":"Reuters","summary":"Kaival Brands Innovations Group Inc :Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial","content":"<html><body><p>Kaival Brands Innovations Group Inc <kavl.o>:Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial Order For Its Flavored Ends.Kaival Brands -  Fda Confirmed That While It Reviews Bidi Vapor'S Request, Its Flavored Bidi Sticks Can Remain On Market Without Threat Of Enforcement.</kavl.o></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Enters Administrative Stay Of BIDI Vapor's Marketing Denial Order For Its Flavored Ends\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-27 20:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Kaival Brands Innovations Group Inc <kavl.o>:Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial Order For Its Flavored Ends.Kaival Brands -  Fda Confirmed That While It Reviews Bidi Vapor'S Request, Its Flavored Bidi Sticks Can Remain On Market Without Threat Of Enforcement.</kavl.o></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KAVL":"Kaival Brands Innovations Group, Inc."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178426233","content_text":"Kaival Brands Innovations Group Inc :Fda Enters Administrative Stay Of Bidi Vapor'S Marketing Denial Order For Its Flavored Ends.Kaival Brands -  Fda Confirmed That While It Reviews Bidi Vapor'S Request, Its Flavored Bidi Sticks Can Remain On Market Without Threat Of Enforcement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855393158,"gmtCreate":1635332928388,"gmtModify":1635332928612,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"🈶️机会吗[财迷]&nbsp;","listText":"🈶️机会吗[财迷]&nbsp;","text":"🈶️机会吗[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855393158","repostId":"2178591283","repostType":2,"repost":{"id":"2178591283","pubTimestamp":1635293340,"share":"https://www.laohu8.com/m/news/2178591283?lang=&edition=full","pubTime":"2021-10-27 08:09","market":"hk","language":"zh","title":"腾讯阅文洽谈收购米读业务 趣头条“潜力股”存变数？","url":"https://stock-news.laohu8.com/highlight/detail?id=2178591283","media":"Tech星球","summary":"上市后沉寂已久的趣头条，正在迎来新的变化。10月26日，Tech星球独家获悉，腾讯阅文集团正在洽谈收购趣头条的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。对此，趣头条和阅文集团均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。","content":"<html><body><div>\n<p><img border=\"0\" height=\"276\" src=\"https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.QTT&amp;imageType=k&amp;token=28dfeb41d35cc81d84b4664d7c23c49f&amp;at=1\" width=\"578\"/></p><p>　　上市后沉寂已久的<span><a href=\"https://laohu8.com/S/QTT\">趣头条</a></span><span></span>，正在迎来新的变化。</p><p>　　10月26日，Tech星球独家获悉，<a href=\"https://laohu8.com/S/00700\">腾讯</a><span><a href=\"https://laohu8.com/S/00772\">阅文集团</a></span>正在洽谈收购<span target=\"_blank\" web=\"1\">趣头条</span>的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。</p><p>　　对此，<span target=\"_blank\" web=\"1\">趣头条</span>和<span target=\"_blank\" web=\"1\">阅文集团</span>均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。</p><p><img border=\"0\" height=\"276\" src=\"https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.00772&amp;imageType=k&amp;token=28dfeb41d35cc81d84b4664d7c23c49f&amp;at=1\" width=\"578\"/></p><p>　　在趣头条上市后，股价一路回落，米读可谓撑起了起用户数增长。此次洽谈出售米读业务，公司内外都对此有不同看法。</p><p><strong>趣头条要出售米读业务？</strong></p><p>　　回顾趣头条的发展历程，可谓是兴起于下沉市场，后探索业务多元化以寻增长点。</p><p>　　趣头条最早以金币打赏模式，迅速占据了下沉市场的新闻资讯App赛道，用了27个月时间完成从App上线到<span>纳斯达克</span><span></span>上市。然而上市后，趣头条市值快速回落，从巅峰的45.88亿美元跌落今天的3亿多美元。</p><p>　　趣头条相比“下沉市场三巨头”中快手与<span><a href=\"https://laohu8.com/S/PDD\">拼多多</a></span><span></span>的千亿市值，则是新闻资讯内容平台的生意模式不性感。</p><p>　　根据趣头条二季度财务数据显示，其二季度营收同比下滑16.6%至12.02亿元，符合市场预期；净亏损2.095亿元，较去年同期小幅收窄。更重要的是，趣头条Q2的DAU同比下滑超30%。</p><p>　　短视频对趣头条主业务的影响较大，如今，<a href=\"https://laohu8.com/S/DYIN\">抖音</a>、快手等短视频产品，挤压资讯类产品的用户使用时长，而且诸如抖音极速版也在使用“网赚”模式拓展用户，这种金币打赏模式对下沉用户的吸引力已经不大。</p><p>　　趣头条积极开展了业务多元化，其关联生态探索的萌推、实惠喵、趣键盘等产品都在此背景下。不过，趣头条旗下增速较快的米读是趣头条的希望。2018年推出的免费阅读App米读小说，公开数据显示，2021年一季度，米读DAU已经突破千万，是趣头条的潜力股。</p><p>　　情形尚且不错的米读，对于外界来说，是一个相对来说吸引人的资产。而对于腾讯阅文，在早期整合起点中文网和QQ阅读等产品后，如今拿下米读也并不意外。相信趣头条也将因此具备更多资源，支撑业务多元化探索。</p><center><img src=\"https://dfscdn.dfcfw.com/download/D25281861554338843917.jpg\" width=\"580\"/></center><p><strong>米读与阅文的 IP 变现路</strong></p><p>　　米读并没有一直甘心仅作免费小说。2020年以来，米读拓展了从网文作品到微短剧的IP孵化链路。</p><p>　　米读在2020年1月就成立了短剧部门，同年4月首个IP微短剧上线。后续联合快手，将平台上《权宠刁妃》《河神的新娘》《秦爷的小哑巴》《重生小甜妻》等44部中腰部作品改编成微短剧，全网播放量超48亿。</p><p>　　据悉，米读开发的IP短剧数量达44部，短剧全网播放量超48亿，环比增长41.18%，全网粉丝总量近2000万，环比增长25%。截至2021年6月，米读签约作者数同比增长52.4%，原创作品数同比增长24.84%。</p><p>　　这与<span target=\"_blank\" web=\"1\">阅文集团</span>的发展思路类似，2020年4月，腾讯集团在阅文内进行管理层换血，同时将付费阅读+买断分成的内容变现模式，变为免费内容引流+IP衍生的流量变现模式，其中IP衍生分为影视、游戏和动漫。</p><p>　　2020年新上任的阅文集团CEO程武，也是腾讯影业CEO，主要使命就是推动阅文的IP衍生变现，尤其是在影视领域的变现。</p><p>　　但富有挑战的地方在于，根据阅文上半年财报显示，阅文自有平台(起点中文网)产品及自营渠道的MAU(平均月活跃用户)同比减少0.3%至截至2.3亿人，其中自有平台产品的MAU由1.3亿人同比减少14.6%至1.14亿人。在大力推行免费的策略下，月活用户的减少值得警惕。</p><p>　　阅文集团CEO程武在财报会电话会议上曾表示，2021年业务重点是增长用户，特别是免费用户方面。收购米读瞬间增加用户数，就显得顺理成章。</p><center><img src=\"https://dfscdn.dfcfw.com/download/D25499129344999273058.jpg\" width=\"580\"/></center><p><strong>网文市场格局面临剧变</strong></p><p>　　目前，免费为主流的网文市场上，已经逐渐形成了两大流派。一是阅文集团免费+IP孵化的模式，这与腾讯的文娱实力分不开，腾讯影业、腾讯动漫、腾讯游戏均有较强的IP开发能力，腾讯视频等提供了很好的发行渠道。</p><p>　　另一派则是新晋崛起的番茄小说。一位网文行业资深人士对Tech星球表示：“番茄小说目前发展比较快，是市场的新变量。”番茄小说走的是广告变现的路线，“番茄小说背靠字节，广告等商业化变现还是不错。”当然，番茄小说在IP储备和开发领域还远逊色于阅文。</p><p>　　在整个网文市场的增长近乎触及天花板的情况下，网文市场的比拼已经远不止在图文内容领域，IP开发能力以及商业化变现，才是决定市场格局的最终变量。</p><p>　　米读在两方面都缺乏靠山，IP开发方面，米读执行的是“二八原则”，也即借助快手合作开发头部的20%作品，余下的则以广告形式变现。在商业化变现方面，财报数据显示，趣头条的广告及市场营收为11.41亿元，与去年同期的13.78亿元相比，同比下降了17.2%。米读对广告投放的吸引力也存在一定的天花板。</p><p>　　在此市场竞争情况下，米读的竞争优势并不明显，加入腾讯阅文的大家庭，似乎是不错的发展路线。</p><p>（文章来源：Tech星球）</p>\n</div></body></html>","source":"eastmoney_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>腾讯阅文洽谈收购米读业务 趣头条“潜力股”存变数？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n腾讯阅文洽谈收购米读业务 趣头条“潜力股”存变数？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 08:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://stock.eastmoney.com/a/202110272156318475_0.html><strong>Tech星球</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>上市后沉寂已久的趣头条，正在迎来新的变化。　　10月26日，Tech星球独家获悉，腾讯阅文集团正在洽谈收购趣头条的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。　　对此，趣头条和阅文集团均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。　　在趣头条...</p>\n\n<a href=\"http://stock.eastmoney.com/a/202110272156318475_0.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com///dfscdn.dfcfw.com/download/D24858633465871654021.jpg?op=imageView2&mode=2&width=256&height=256&quality=70&format=png","relate_stocks":{"00700":"腾讯控股","TCEHY":"腾讯控股ADR","QTT":"趣头条"},"source_url":"http://stock.eastmoney.com/a/202110272156318475_0.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178591283","content_text":"上市后沉寂已久的趣头条，正在迎来新的变化。　　10月26日，Tech星球独家获悉，腾讯阅文集团正在洽谈收购趣头条的网文业务“米读”，交易已经接近完成。一直以来，阅文与米读、掌阅等平台在免费内容方面有长期合作。如果此次收购达成，将有助于增强阅文的用户基数与IP储备。　　对此，趣头条和阅文集团均对Tech星球表示，此消息不实，二者仅限于内容合作。但行业信源验证了这一消息真实性，正在进行中。　　在趣头条上市后，股价一路回落，米读可谓撑起了起用户数增长。此次洽谈出售米读业务，公司内外都对此有不同看法。趣头条要出售米读业务？　　回顾趣头条的发展历程，可谓是兴起于下沉市场，后探索业务多元化以寻增长点。　　趣头条最早以金币打赏模式，迅速占据了下沉市场的新闻资讯App赛道，用了27个月时间完成从App上线到纳斯达克上市。然而上市后，趣头条市值快速回落，从巅峰的45.88亿美元跌落今天的3亿多美元。　　趣头条相比“下沉市场三巨头”中快手与拼多多的千亿市值，则是新闻资讯内容平台的生意模式不性感。　　根据趣头条二季度财务数据显示，其二季度营收同比下滑16.6%至12.02亿元，符合市场预期；净亏损2.095亿元，较去年同期小幅收窄。更重要的是，趣头条Q2的DAU同比下滑超30%。　　短视频对趣头条主业务的影响较大，如今，抖音、快手等短视频产品，挤压资讯类产品的用户使用时长，而且诸如抖音极速版也在使用“网赚”模式拓展用户，这种金币打赏模式对下沉用户的吸引力已经不大。　　趣头条积极开展了业务多元化，其关联生态探索的萌推、实惠喵、趣键盘等产品都在此背景下。不过，趣头条旗下增速较快的米读是趣头条的希望。2018年推出的免费阅读App米读小说，公开数据显示，2021年一季度，米读DAU已经突破千万，是趣头条的潜力股。　　情形尚且不错的米读，对于外界来说，是一个相对来说吸引人的资产。而对于腾讯阅文，在早期整合起点中文网和QQ阅读等产品后，如今拿下米读也并不意外。相信趣头条也将因此具备更多资源，支撑业务多元化探索。米读与阅文的 IP 变现路　　米读并没有一直甘心仅作免费小说。2020年以来，米读拓展了从网文作品到微短剧的IP孵化链路。　　米读在2020年1月就成立了短剧部门，同年4月首个IP微短剧上线。后续联合快手，将平台上《权宠刁妃》《河神的新娘》《秦爷的小哑巴》《重生小甜妻》等44部中腰部作品改编成微短剧，全网播放量超48亿。　　据悉，米读开发的IP短剧数量达44部，短剧全网播放量超48亿，环比增长41.18%，全网粉丝总量近2000万，环比增长25%。截至2021年6月，米读签约作者数同比增长52.4%，原创作品数同比增长24.84%。　　这与阅文集团的发展思路类似，2020年4月，腾讯集团在阅文内进行管理层换血，同时将付费阅读+买断分成的内容变现模式，变为免费内容引流+IP衍生的流量变现模式，其中IP衍生分为影视、游戏和动漫。　　2020年新上任的阅文集团CEO程武，也是腾讯影业CEO，主要使命就是推动阅文的IP衍生变现，尤其是在影视领域的变现。　　但富有挑战的地方在于，根据阅文上半年财报显示，阅文自有平台(起点中文网)产品及自营渠道的MAU(平均月活跃用户)同比减少0.3%至截至2.3亿人，其中自有平台产品的MAU由1.3亿人同比减少14.6%至1.14亿人。在大力推行免费的策略下，月活用户的减少值得警惕。　　阅文集团CEO程武在财报会电话会议上曾表示，2021年业务重点是增长用户，特别是免费用户方面。收购米读瞬间增加用户数，就显得顺理成章。网文市场格局面临剧变　　目前，免费为主流的网文市场上，已经逐渐形成了两大流派。一是阅文集团免费+IP孵化的模式，这与腾讯的文娱实力分不开，腾讯影业、腾讯动漫、腾讯游戏均有较强的IP开发能力，腾讯视频等提供了很好的发行渠道。　　另一派则是新晋崛起的番茄小说。一位网文行业资深人士对Tech星球表示：“番茄小说目前发展比较快，是市场的新变量。”番茄小说走的是广告变现的路线，“番茄小说背靠字节，广告等商业化变现还是不错。”当然，番茄小说在IP储备和开发领域还远逊色于阅文。　　在整个网文市场的增长近乎触及天花板的情况下，网文市场的比拼已经远不止在图文内容领域，IP开发能力以及商业化变现，才是决定市场格局的最终变量。　　米读在两方面都缺乏靠山，IP开发方面，米读执行的是“二八原则”，也即借助快手合作开发头部的20%作品，余下的则以广告形式变现。在商业化变现方面，财报数据显示，趣头条的广告及市场营收为11.41亿元，与去年同期的13.78亿元相比，同比下降了17.2%。米读对广告投放的吸引力也存在一定的天花板。　　在此市场竞争情况下，米读的竞争优势并不明显，加入腾讯阅文的大家庭，似乎是不错的发展路线。（文章来源：Tech星球）","news_type":1},"isVote":1,"tweetType":1,"viewCount":421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855302047,"gmtCreate":1635332409789,"gmtModify":1635332409985,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不知道又🈶️多少人被套了[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不知道又🈶️多少人被套了[捂脸]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$不知道又🈶️多少人被套了[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855302047","isVote":1,"tweetType":1,"viewCount":310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856171655,"gmtCreate":1635165194836,"gmtModify":1635165195578,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BENE\">$Benessere Capital Acquisition Corp(BENE)$</a>感觉这个今晚会涨一波[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BENE\">$Benessere Capital Acquisition Corp(BENE)$</a>感觉这个今晚会涨一波[捂脸]&nbsp;","text":"$Benessere Capital Acquisition Corp(BENE)$感觉这个今晚会涨一波[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856171655","isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856150651,"gmtCreate":1635163148039,"gmtModify":1635163148767,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>8点一到就飞漲[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/DWAC\">$Digital World Acquisition Corp(DWAC)$</a>8点一到就飞漲[捂脸]&nbsp;","text":"$Digital World Acquisition Corp(DWAC)$8点一到就飞漲[捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856150651","isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":338024934,"gmtCreate":1609777777128,"gmtModify":1703740488815,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>睡了 晚安😴明早0.55见[微笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>睡了 晚安😴明早0.55见[微笑]&nbsp;","text":"$Sundial Growers Inc.(SNDL)$睡了 晚安😴明早0.55见[微笑]","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":20,"commentSize":23,"repostSize":0,"link":"https://laohu8.com/post/338024934","isVote":1,"tweetType":1,"viewCount":3761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":155986498,"gmtCreate":1625369443714,"gmtModify":1631885073888,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRIN\">$Marin Software Inc.(MRIN)$</a>下周开盤会是怎樣個走法呢[开心]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/MRIN\">$Marin Software Inc.(MRIN)$</a>下周开盤会是怎樣個走法呢[开心]&nbsp;[财迷]&nbsp;","text":"$Marin Software Inc.(MRIN)$下周开盤会是怎樣個走法呢[开心] [财迷]","images":[{"img":"https://static.tigerbbs.com/389b60d9bad21cfd8a83b8546984f10d","width":"750","height":"1300"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":10,"commentSize":16,"repostSize":1,"link":"https://laohu8.com/post/155986498","isVote":1,"tweetType":1,"viewCount":967,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3553387701150566","authorId":"3553387701150566","name":"才神","avatar":"https://static.tigerbbs.com/fac8301d590c4dfdd3a0f722b51a2767","crmLevel":2,"crmLevelSwitch":0},"content":"上冲不过25就要走","text":"上冲不过25就要走","html":"上冲不过25就要走"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":140741625,"gmtCreate":1625677058467,"gmtModify":1631889915747,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>先睡去了[真香]&nbsp;明早盘后見4.00希望[财迷]&nbsp;[比心]&nbsp;[比心]&nbsp;晚安💤大家","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>先睡去了[真香]&nbsp;明早盘后見4.00希望[财迷]&nbsp;[比心]&nbsp;[比心]&nbsp;晚安💤大家","text":"$Exela Technologies, Inc.(XELA)$先睡去了[真香] 明早盘后見4.00希望[财迷] [比心] [比心] 晚安💤大家","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":9,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/140741625","isVote":1,"tweetType":1,"viewCount":1820,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3560245986941518","authorId":"3560245986941518","name":"馆小鱼","avatar":"https://static.tigerbbs.com/b9bbbe3a96ac3b3ca210c36bb462abf0","crmLevel":2,"crmLevelSwitch":0},"content":"厉害了 我是不敢过夜 再看一会儿","text":"厉害了 我是不敢过夜 再看一会儿","html":"厉害了 我是不敢过夜 再看一会儿"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842039007,"gmtCreate":1636119750425,"gmtModify":1636119751182,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ALZN\">$Alzamend Neuro, Inc(ALZN)$</a>错过了沒话讲[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Alzamend Neuro, Inc(ALZN)$错过了沒话讲[捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":13,"repostSize":0,"link":"https://laohu8.com/post/842039007","isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":146707135,"gmtCreate":1626098493427,"gmtModify":1631884025368,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不管你現在是跌还是漲[微笑]&nbsp;[微笑]&nbsp;只要沒達到我心目中5美元以上的目標我就是不卖[开心]&nbsp;[开心]&nbsp;[龇牙]&nbsp;[龇牙]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>不管你現在是跌还是漲[微笑]&nbsp;[微笑]&nbsp;只要沒達到我心目中5美元以上的目標我就是不卖[开心]&nbsp;[开心]&nbsp;[龇牙]&nbsp;[龇牙]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$不管你現在是跌还是漲[微笑] [微笑] 只要沒達到我心目中5美元以上的目標我就是不卖[开心] [开心] [龇牙] [龇牙]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/146707135","isVote":1,"tweetType":1,"viewCount":1076,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":126388131,"gmtCreate":1624544610523,"gmtModify":1631888810750,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DBGI\">$Digital Brands Group, Inc.(DBGI)$</a>繼續飛漲吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","listText":"<a href=\"https://laohu8.com/S/DBGI\">$Digital Brands Group, Inc.(DBGI)$</a>繼續飛漲吧[财迷]&nbsp;[财迷]&nbsp;[看涨]&nbsp;[看涨]&nbsp;[看涨]&nbsp;","text":"$Digital Brands Group, Inc.(DBGI)$繼續飛漲吧[财迷] [财迷] [看涨] [看涨] [看涨]","images":[{"img":"https://static.tigerbbs.com/edd85ad3c07339ead0d18d7d77d0efee","width":"750","height":"1300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/126388131","isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":895777736,"gmtCreate":1628776293125,"gmtModify":1631883841375,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>最新消息[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>最新消息[财迷]&nbsp;[财迷]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$最新消息[财迷] [财迷]","images":[{"img":"https://static.tigerbbs.com/c600d8e13ad8bf726febc5ffb25d1bf8","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/895777736","isVote":1,"tweetType":1,"viewCount":1129,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583721639469341","authorId":"3583721639469341","name":"燕风玉琯","avatar":"https://static.tigerbbs.com/dbf6e775ee4ae1e55c71603c66640bf5","crmLevel":2,"crmLevelSwitch":0},"content":"利好还是利空","text":"利好还是利空","html":"利好还是利空"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":160281545,"gmtCreate":1623799614987,"gmtModify":1631886936301,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/COCP\">$Cocrystal Pharma, Inc.(COCP)$</a>又見消息出來了[得意]&nbsp;[得意]&nbsp;[财迷]&nbsp;[强]&nbsp;[强]&nbsp;","listText":"<a href=\"https://laohu8.com/S/COCP\">$Cocrystal Pharma, Inc.(COCP)$</a>又見消息出來了[得意]&nbsp;[得意]&nbsp;[财迷]&nbsp;[强]&nbsp;[强]&nbsp;","text":"$Cocrystal Pharma, Inc.(COCP)$又見消息出來了[得意] [得意] [财迷] [强] [强]","images":[{"img":"https://static.tigerbbs.com/2e57d93a81fa60db077612042f59c5f0","width":"750","height":"1624"},{"img":"https://static.tigerbbs.com/b7faa989a11024e89ee8b4dd04132ba5","width":"750","height":"1624"},{"img":"https://static.tigerbbs.com/9c2d2cd83d76fb4ebc537b01ee713f60","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/160281545","isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3560245986941518","authorId":"3560245986941518","name":"馆小鱼","avatar":"https://static.tigerbbs.com/b9bbbe3a96ac3b3ca210c36bb462abf0","crmLevel":2,"crmLevelSwitch":0},"content":"成交量太低了。资金也不进场","text":"成交量太低了。资金也不进场","html":"成交量太低了。资金也不进场"}],"imageCount":3,"langContent":"CN","totalScore":0},{"id":139820038,"gmtCreate":1621607291424,"gmtModify":1634187682470,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/YALA\">$Yalla Group(YALA)$</a>🈳️头剩3⃣️千票了[开心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/YALA\">$Yalla Group(YALA)$</a>🈳️头剩3⃣️千票了[开心]&nbsp;","text":"$Yalla Group(YALA)$🈳️头剩3⃣️千票了[开心]","images":[{"img":"https://static.tigerbbs.com/791c56dbee15147d4552729d69f5e4e1","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/139820038","isVote":1,"tweetType":1,"viewCount":1650,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3495693900287878","authorId":"3495693900287878","name":"财神驾到008","avatar":"https://static.tigerbbs.com/1320fb557570aca9b5829ed771ea1cd7","crmLevel":2,"crmLevelSwitch":0},"content":"现在又有4000了","text":"现在又有4000了","html":"现在又有4000了"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":135820826,"gmtCreate":1622158300865,"gmtModify":1631887563929,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOED\">$1847 Goedeker(GOED)$</a>這是我看過杀的最多人的1⃣️個股[捂脸]&nbsp;[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/GOED\">$1847 Goedeker(GOED)$</a>這是我看過杀的最多人的1⃣️個股[捂脸]&nbsp;[捂脸]&nbsp;[捂脸]&nbsp;","text":"$1847 Goedeker(GOED)$這是我看過杀的最多人的1⃣️個股[捂脸] [捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":9,"repostSize":0,"link":"https://laohu8.com/post/135820826","isVote":1,"tweetType":1,"viewCount":1650,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576915339464459","authorId":"3576915339464459","name":"yqpcnc","avatar":"https://static.tigerbbs.com/a461ab206fa5540b00f31ff42b046f29","crmLevel":2,"crmLevelSwitch":0},"content":"这是啥情况1","text":"这是啥情况1","html":"这是啥情况1"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":313248063,"gmtCreate":1611730809352,"gmtModify":1703752699378,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SCIE\">$SpectraSCIENCE, Inc.(SCIE)$</a>二十萬股看你怎樣飛天遁地[你懂的]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SCIE\">$SpectraSCIENCE, Inc.(SCIE)$</a>二十萬股看你怎樣飛天遁地[你懂的]&nbsp;","text":"$SpectraSCIENCE, Inc.(SCIE)$二十萬股看你怎樣飛天遁地[你懂的]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":9,"repostSize":0,"link":"https://laohu8.com/post/313248063","isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3493637137407258","authorId":"3493637137407258","name":"邱茗","avatar":"https://static.tigerbbs.com/468dfe96afb27ebee4e6ce26db9dc572","crmLevel":2,"crmLevelSwitch":0},"content":"哈哈，涨到一块你刺不刺激","text":"哈哈，涨到一块你刺不刺激","html":"哈哈，涨到一块你刺不刺激"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":338374675,"gmtCreate":1609843687797,"gmtModify":1703740810221,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>股東们啊[开心]&nbsp;你们看今晚會超過1⃣️塊吗[笑哭]&nbsp;[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>股東们啊[开心]&nbsp;你们看今晚會超過1⃣️塊吗[笑哭]&nbsp;[笑哭]&nbsp;","text":"$Sundial Growers Inc.(SNDL)$股東们啊[开心] 你们看今晚會超過1⃣️塊吗[笑哭] [笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/338374675","isVote":1,"tweetType":1,"viewCount":2144,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3561609070329626","authorId":"3561609070329626","name":"八球","avatar":"https://static.tigerbbs.com/a017e35bb7a4855d2dcf10e264f03d2f","crmLevel":2,"crmLevelSwitch":0},"content":"亲人们胆子在大点，说好干掉苹果的呢 [开心]","text":"亲人们胆子在大点，说好干掉苹果的呢 [开心]","html":"亲人们胆子在大点，说好干掉苹果的呢 [开心]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":395868718,"gmtCreate":1607617916934,"gmtModify":1703849144375,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>我受不了跑了[笑哭]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>我受不了跑了[笑哭]&nbsp;","text":"$Sundial Growers Inc.(SNDL)$我受不了跑了[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":8,"repostSize":0,"link":"https://laohu8.com/post/395868718","isVote":1,"tweetType":1,"viewCount":2094,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3529879938204968","authorId":"3529879938204968","name":"恶灵下单员","avatar":"https://static.tigerbbs.com/96e1f2f30216ec29d09fd144e29c0436","crmLevel":2,"crmLevelSwitch":0},"content":"赶紧接回来，北京时间凌晨3点左右行情开始","text":"赶紧接回来，北京时间凌晨3点左右行情开始","html":"赶紧接回来，北京时间凌晨3点左右行情开始"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":896796096,"gmtCreate":1628604291815,"gmtModify":1631883841495,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>今晚讓我們一起感受飞翔的吧[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>今晚讓我們一起感受飞翔的吧[财迷]&nbsp;[财迷]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$今晚讓我們一起感受飞翔的吧[财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/896796096","isVote":1,"tweetType":1,"viewCount":1520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":833033772,"gmtCreate":1629188339196,"gmtModify":1631883841224,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>老虎到現在连财报也不放出来了[愤怒]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>老虎到現在连财报也不放出来了[愤怒]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$老虎到現在连财报也不放出来了[愤怒]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/833033772","isVote":1,"tweetType":1,"viewCount":1634,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3580427134668638","authorId":"3580427134668638","name":"62984650","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0},"content":"老虎想干嘛？要死就死个痛快！","text":"老虎想干嘛？要死就死个痛快！","html":"老虎想干嘛？要死就死个痛快！"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":152842565,"gmtCreate":1625283692757,"gmtModify":1631888957165,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/STAF\">$Staffing 360 Solutions Inc.(STAF)$</a>我相信你很快就会回來了[开心]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/STAF\">$Staffing 360 Solutions Inc.(STAF)$</a>我相信你很快就会回來了[开心]&nbsp;[财迷]&nbsp;","text":"$Staffing 360 Solutions Inc.(STAF)$我相信你很快就会回來了[开心] [财迷]","images":[{"img":"https://static.tigerbbs.com/c2f43c1d2c3f9bc9ccded1a6e2ca2137","width":"750","height":"1456"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/152842565","isVote":1,"tweetType":1,"viewCount":1035,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":897958613,"gmtCreate":1628870034732,"gmtModify":1631883841322,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>跌吧你[龇牙]&nbsp;我怕你到漲的時候像只野🐎我会拉不住[龇牙]&nbsp;[龇牙]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>跌吧你[龇牙]&nbsp;我怕你到漲的時候像只野🐎我会拉不住[龇牙]&nbsp;[龇牙]&nbsp;[财迷]&nbsp;[财迷]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$跌吧你[龇牙] 我怕你到漲的時候像只野🐎我会拉不住[龇牙] [龇牙] [财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897958613","isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":899806537,"gmtCreate":1628171966729,"gmtModify":1631883841713,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>利好一大堆[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;長期持🈶️[财迷]&nbsp;[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>利好一大堆[开心]&nbsp;[开心]&nbsp;[开心]&nbsp;長期持🈶️[财迷]&nbsp;[财迷]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$利好一大堆[开心] [开心] [开心] 長期持🈶️[财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/899806537","isVote":1,"tweetType":1,"viewCount":1406,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586525847490973","authorId":"3586525847490973","name":"柿子娘娘","avatar":"https://static.tigerbbs.com/0fd45d1c0fd142ac0b49a85b516ff7a3","crmLevel":2,"crmLevelSwitch":0},"content":"利好在哪里","text":"利好在哪里","html":"利好在哪里"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":145197466,"gmtCreate":1626194289055,"gmtModify":1631884023130,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>睡觉了💤明早6.50美元见[爱你]&nbsp;[比心]&nbsp;[比心]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>睡觉了💤明早6.50美元见[爱你]&nbsp;[比心]&nbsp;[比心]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$睡觉了💤明早6.50美元见[爱你] [比心] [比心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/145197466","isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":835487565,"gmtCreate":1629732236657,"gmtModify":1631883841062,"author":{"id":"3562033051306615","authorId":"3562033051306615","name":"邁向狙擊之路","avatar":"https://static.tigerbbs.com/8d8a53a3b0a071a5f63d4eba17f5e18e","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>信息過了几天現在才放出來🥲真的是晕[捂脸]&nbsp;[捂脸]&nbsp;","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>信息過了几天現在才放出來🥲真的是晕[捂脸]&nbsp;[捂脸]&nbsp;","text":"$Exela Technologies, Inc.(XELA)$信息過了几天現在才放出來🥲真的是晕[捂脸] [捂脸]","images":[{"img":"https://static.tigerbbs.com/5cfc1613753165ab65eae7dc5b18a5bd","width":"750","height":"1624"},{"img":"https://static.tigerbbs.com/2775dbc62a29714111e2ccbe9e339167","width":"750","height":"1624"},{"img":"https://static.tigerbbs.com/4fb056d757eb0338c4d8bd50564b203b","width":"750","height":"1624"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/835487565","isVote":1,"tweetType":1,"viewCount":1191,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586525847490973","authorId":"3586525847490973","name":"柿子娘娘","avatar":"https://static.tigerbbs.com/0fd45d1c0fd142ac0b49a85b516ff7a3","crmLevel":2,"crmLevelSwitch":0},"content":"我的也没有","text":"我的也没有","html":"我的也没有"}],"imageCount":3,"langContent":"CN","totalScore":0}],"lives":[]}